We are proud to announce that thanks to the hard work of our Intervention Cardiology team in Saudi Arabia, the first DynamX implant case was successfully performed in KSA this 5th June 2021 at Al Mana General Hospital in Dammam.

It is the first time in Saudi Arabia that we use such an innovative system to treat coronary artery diseases. The DynamX™ Drug Eluting Coronary Bioadaptor System from our principal company Elixir is the first coronary artery implant designed to adapt to vessel physiology and the Doctor who operated gave a very good initial feedback on its performance.

The DynamX System initially functions like a traditional drug-eluting stent (DES) with similar deliverability and radial strength while the vessel heals. Over six months the polymer is resorbed, releasing the uncaging elements to safely allow for positive adaptive remodelling and restoration of vessel function.

Congratulations to Ahmad Hoblos and the Intervention Cardiology team for this achievement.

We proudly announce that Zahrawi Group Haematology & Biochemistry unit in Qatar has successfully installed the first Sysmex Urinalysis Automation line at the prestigious Doha Clinic Hospital on the 9th March followed by a training on the 14th March. Our teams in Qatar completed this task despite all the obstacles and restrictions related to the COVID-19 situation as well as the fierce competition in Qatari market.

Thanks to the hard work and efforts of the Haematology & Biochemistry sales team along with the support of our service unit, this win against our competition was made possible. Once again Zahrawi Group went the extra mile for its customers in order to deliver the best in term of medical solutions.

Most importantly, Doha Clinic Hospital staff were happy and satisfied as this system would enable them to have fully automated urinalysis workflow solution of the highest level towards a better patient care.

Copyright Al-Zahrawi Medical Supplies Est 2019 All rights reserved

Website by: Zahrawi Group